Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 157   

Articles published

NVS 78.13 +2.34 (3.09%)
price chart
How Many Novartis AG (ADR) (NYSE:NVS)'s Analysts Are Bullish?
Out of 4 analysts covering Novartis Ag (NYSE:NVS), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive.
Bryn Mawr Trust Company Decreased Stake in Novartis Ag Sponsored Adr (NYSE ...  CCH Daily News
Stocks Going Up: Novartis AG (ADR)(NYSE:NVS), Monsanto Company(NYSE:MON)  NYSE Journal (press release)
Can Novartis' Entresto be the New Blockbuster?
Novartis AG (NYSE:NVS) announced that its cardiology drug Entresto (sacubitril/valsartan) has finally got an approval under the new guidelines for the management of heart failure and its allied ailments.
Novartis, Amgen to See Higher Sales of New Heart Drugs  Bidness ETC
Novartis' Heart Drug Entresto Receives Class I Endorsement From U.S. and ...  Sonoran Weekly Review
Novartis AG (ADR) Gaps Up; Strong Momentum for Buyers
The stock of Novartis AG (ADR) (NYSE:NVS) gapped up by $0.35 today and has $118.23 target or 56.00% above today's $75.79 share price.
Can Novartis AG (ADR) Reach Financial Stability via Restructuring?
As Novartis AG (ADR) (NYSE:NVS) head of pharmaceuticals, David Epstein, announced his departure from the company, it initiated the process of restructuring the business portfolios.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis Continues Efforts To Gain Larger Market For Entresto
Novartis AG (ADR) (NYSE:NVS) is working diligently to bring back heart failure drug Entresto, after the drug's not-so-impressive introduction in the market.
Attention Grabbing Stocks of Healthcare: CIGNA Corporation (NYSE:CI), Novartis ...
Shares of CIGNA Corporation (NYSE:CI) fell -2.04% to $132.18 at 12:51 PM EDT. The stock attained the volume of 1.24 Million shares recently versus average trading volume of 1.29 Million shares.
Price Target Summary: Novartis AG (ADR) (NYSE:NVS)
The Company gained 0.07% and finished at $75.76. The daily volume was measured at 2.19 million shares. The 52-week high of the share price is $106.84 and the 52-week low is $69.89.
Novartis AG (ADR) (NYSE:NVS): Big Market Mover
[Market Realist] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) reported a rise of ~1% in its revenue on a constant currency basis in its 1Q16 earnings.
Novartis AG (ADR) (NYSE:NVS) Sells 14 Drug Brands Worth $293 Million To Sun In ...
Novartis AG (ADR) (NYSE:NVS) has sold more than a dozen drugs to India's Sun Pharmaceutical in Japan. The development follows a trend that has become popular among major pharmaceutical companies.
Novartis AG (NVS) Rating Lowered to Neutral at Citigroup Inc.  South Florida Hedge Fund Managers
Novartis Is Under SEC Investigation, Probes Reporter Says  Benzinga